[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "ANY II not README developmental stage TMT YAML CELL MAGE PATCH NCI NOTE UBERON IMPLIED PROTEOMICS LIMITED MIAPE CF BMC COLUMN IMPORTANT PSI HF MERCHANTABILITY SDRF EBI file your FITNESS SRM ancestry category disease CV PTM SILAC JA STANDARDS cell type PRIDE:0000659 PRIDE pooled sample biosample accession number PRIDE:0000833 HUPO MS PP MHC NCIT DJ HEREIN PMCID AS SN NOT PRIDE:0000832 III LI WILL WARRANTY PURPOSE CLO PATO:0000461 data file FAIR DOID INFRINGE spiked compound MS:1000484 PRIDE:0000831 biological replicate ZFA SP DISCLAIMS SAMEA INITIATIVE MIAME individual IDF RFC OF AND TA HTML BUT label PRIDE:0000590 SHALL RAW ID LC TAB SWATH BTO disease stage MT NCIT:C25683 PRM EM MAY TO MC RIGHTS MAJOR NCBI DIA VK WARRANTIES HANCESTRO EXPRESS ENVO QY OR organism part ALL FOR DDA VCF THAT XML age USE URI MINOR CN PEPTIDESEQ PS PMID PARTICULAR AC CT COULD REQUIRES BE technical replicate RECOMMEND SAMN NCIT:C25714 sex CPTAC ISA organism cleavage agent details CS fraction identifier URL RECOMMENDED NT MOD REQUIRED mass SHOULD TIP instrument PRIDE:0000834 HCD FDR MS:1001251 exclamation CL THE OPTIONAL BRENDA PO MUST ROW source name PATO INCLUDING sample EW HLA IS INFORMATION EFO MONDO characteristics proteomics data acquisition method ..."
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship Format (SDRF)-Proteomics. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is: HUPO-PSI SDRF.\n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community .\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often prevents dat",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "ANY II README TMT YAML CELL MAGE PATCH NCI UBERON IMPLIED PROTEOMICS LIMITED MIAPE CF BMC COLUMN PSI HF MERCHANTABILITY SDRF EBI FITNESS SRM disease CV PTM SILAC JA STANDARDS cell type PRIDE:0000659 PRIDE pooled sample biosample accession number PRIDE:0000833 HUPO MS PP MHC NCIT DJ HEREIN PMCID AS SN NOT PRIDE:0000832 III LI WILL WARRANTY PURPOSE CLO PATO:0000461 data file FAIR DOID INFRINGE spiked compound MS:1000484 PRIDE:0000831 biological replicate ZFA SP DISCLAIMS SAMEA INITIATIVE MIAME individual IDF RFC OF AND TA HTML BUT label PRIDE:0000590 SHALL RAW LC TAB SWATH BTO disease stage MT NCIT:C25683 PRM EM MAY TO MC RIGHTS MAJOR NCBI DIA VK WARRANTIES HANCESTRO EXPRESS ENVO QY OR organism part ALL FOR DDA VCF THAT age USE URI MINOR CN PEPTIDESEQ PS PMID PARTICULAR AC CT REQUIRES COULD BE technical replicate RECOMMEND SAMN NCIT:C25714 sex CPTAC ISA organism cleavage agent details CS fraction identifier URL RECOMMENDED NT MOD REQUIRED mass SHOULD instrument PRIDE:0000834 HCD FDR MS:1001251 CL THE OPTIONAL BRENDA PO MUST ROW PATO INCLUDING EW HLA IS INFORMATION EFO MONDO proteomics data acquisition method ..."
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000235 developmental stage MAY MONDO:0005148 COVID organism depletion CL:0000815 PATO:0000461 NOTE NCBI UBERON:0000178 UBERON DOID CL:0000066 UBERON:0000955 CL:0000236 UBERON:0000948 PATO:0001421 CL:0000057 CL:0000624 MONDO:0004975 CL exclamation SDRF MONDO:0004989 organism part age synthetic peptide PO MUST xenograft enrichment process PATO disease PTM UBERON:0002107 PDX cell type UBERON:0002113 EFO MONDO APP ID CL:0000084 MONDO:0100096 UBERON:0001969"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\nrattus norvegicus |NCBITaxon:10116 |Rat\ndanio rerio |NCBITaxon:7955 |Zebrafish\ndrosophila melanogaster |NCBITaxon:7227 |Fruit fly\narabidopsis thaliana |NCBITaxon:3702 |Thale cress\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nblood plasma |UBERON:0001969 |Blood plasma\nliver |UBERON:0002107 |Liver tissue\nbrain |UBERON:0000955 |Brain\nheart |UBERON:0000948 |Heart\nkidney |UBERON:0002113 |Kidney\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hou",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000235 developmental stage MAY MONDO:0005148 COVID organism depletion CL:0000815 PATO:0000461 NCBI UBERON:0000178 UBERON DOID CL:0000066 UBERON:0000955 CL:0000236 UBERON:0000948 PATO:0001421 CL:0000057 CL:0000624 MONDO:0004975 CL SDRF MONDO:0004989 organism part age synthetic peptide PO MUST xenograft enrichment process PATO disease PTM UBERON:0002107 PDX cell type UBERON:0002113 EFO MONDO APP ID CL:0000084 MONDO:0100096 UBERON:0001969"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "disease stage NCIT:C65108 HIPAA breast cancer subtype NCIT compound MONDO:0005148 NCIT:C18206 Ann Arbor stage CHEBI:27899 MONDO:0005044 NCI NCIT:C27971 treatment status ER NCIT:C27966 IV NCIT:C15262 PR tumor grade treatment smoking status CHEBI:28748 IMPORTANT TNM GDPR HANCESTRO TNM staging menopausal status exclamation HANCESTRO:0009 SDRF dose individual NCIT:C28078 organism part NCIT:C15632 ancestry category pre-existing condition Dukes stage HANCESTRO:0005 NCIT:C28076 NCIT:C71732 AJCC MONDO NCIT:C65106 NCIT:C65107 treatment response ID NCIT:C4870 body mass index NCIT:C53554 sampling time point weight"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "disease stage NCIT:C65108 HIPAA breast cancer subtype NCIT compound MONDO:0005148 NCIT:C18206 Ann Arbor stage CHEBI:27899 MONDO:0005044 NCI NCIT:C27971 treatment status ER NCIT:C27966 IV NCIT:C15262 PR tumor grade treatment smoking status CHEBI:28748 HANCESTRO TNM GDPR TNM staging menopausal status HANCESTRO:0009 SDRF dose individual NCIT:C28078 organism part NCIT:C15632 ancestry category pre-existing condition Dukes stage HANCESTRO:0005 NCIT:C28076 NCIT:C71732 AJCC MONDO NCIT:C65106 NCIT:C65107 treatment response ID NCIT:C4870 body mass index NCIT:C53554 sampling time point weight"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001309 SDS README PAGE MS:1001306 TMT UVPD NOTE fragment mass tolerance MS:1000133 dissociation method CAA NCE PSI HF SH MS:1001303 SDRF PRIDE:0000565 MS:1000081 PRIDE:0000561 IAA CV UNIMOD:21 SILAC PRIDE MS:1000264 MS1 scan range UNIMOD:4 MS PP IAM depletion TCEP ETD MS:1000484 MS:1000443 OLS modification parameters TA label PRIDE:0000564 PRIDE:0000590 TOF PRIDE:0000553 MT MS:1000598 UNIMOD MS:1000084 DIA reduction reagent MS:1001917 MS:1001045 MS:1001313 PRIDE:0000285 precursor mass tolerance PRIDE:0000551 DTT AC fractionation method MS:1002523 scan window lower limit SCX cleavage agent details fraction identifier RECOMMENDED NT MOD REQUIRED collision energy TIP HCD UNIMOD:1 MS:1001251 exclamation MS2 mass analyzer CID MS:1002631 scan window upper limit MS:1000422 MS:1003246 UNIMOD:35 alkylation reagent"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides detailed guidelines for data file metadata fields that require specific formatting or have complex standardization requirements. For basic field descriptions, see the main SDRF-Proteomics specification.\n\nVersion 1.0.0 - 2025-01\n\nCV Term Format\n\nFor data file metadata columns that reference ontology terms, use the structured CV term format:\n\nNT={term name};AC={accession}\n\nExamples:\n\n- Dissociation method: NT=HCD;AC=PRIDE:0000590\n- Fractionation method: NT=High-pH reversed-phase chromatography;AC=PRIDE:0000564\n- Instrument: NT=Q Exactive HF;AC=MS:1002523\n- Label: NT=TMT126;AC=PRIDE:0000285\n\nWhy use the structured format?\n\n1. Automated annotation: Many data file properties (instrument, acquisition method, dissociation method) can be automatically determined by software from raw files.\n2. Validation: Accession numbers enable automated validation against ontologies.\n3. Interoperability: Structured terms are unambiguous across different tools and databases.\n\n Unlike sample metadata (characteristics) which are typically annotated manually using simple term names, data file metadata benefits from the structured CV term format because these values are often extracted programmatically from instrument files.\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119, iTRAQ121\n\nSILAC labels: SILAC light, SILAC medium, SILAC heavy\n\nMS2 Mass Analyzer\n\nColumn: comment[MS2 mass analyzer]\n\nOntology: PSI-MS - Mass analyzer type (MS:1000443)\n\nSpecifies the analyzer used for MS2 scans. Important for hybrid instruments.\n\nCommon values:\n\nAnalyzer |Accession\n\norbitrap |MS:100",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001309 SDS PAGE MS:1001306 TMT UVPD fragment mass tolerance MS:1000133 dissociation method CAA NCE PSI HF SH MS:1001303 SDRF PRIDE:0000565 MS:1000081 PRIDE:0000561 IAA CV UNIMOD:21 SILAC PRIDE MS:1000264 MS1 scan range UNIMOD:4 MS PP IAM depletion TCEP ETD MS:1000484 MS:1000443 OLS modification parameters TA label PRIDE:0000564 PRIDE:0000590 TOF PRIDE:0000553 MT MS:1000598 UNIMOD MS:1000084 DIA reduction reagent MS:1001917 MS:1001045 MS:1001313 PRIDE:0000285 precursor mass tolerance PRIDE:0000551 DTT AC fractionation method MS:1002523 scan window lower limit SCX cleavage agent details fraction identifier RECOMMENDED NT MOD REQUIRED collision energy HCD UNIMOD:1 MS:1001251 MS2 mass analyzer CID MS:1002631 scan window upper limit MS:1000422 MS:1003246 UNIMOD:35 alkylation reagent"
  }
]